Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Submission of Matters to a Vote of Security Holders, Regulation FD Disclo-S4

Thank you for the link.....from that disclosure

Item 7.01 Regulation FD Disclosure.

As previously disclosed by the Company, a complaint was filed on behalf of the Company and other parties in the U.S. International Trade Commission ("ITC") on July 24, 2012 (ITC Investigation No. 337-TA-853, or the "853 Investigation") alleging infringement of the '336 patent against respondents Acer Inc., Amazon.com Inc., Barnes & Noble Inc., Garmin Ltd., HTC Corporation, Huawei Technologies Co. Ltd., Kyocera Corporation, LG Electronics, Nintendo Co. Ltd., Novatel Wireless Inc., Samsung Electronics Co. Ltd., Sierra Wireless Inc., and ZTE Corporation ("Respondents"). Sierra Wireless purchased a license to the MMP Portfolio and was terminated from the 853 Investigation in November 2012.

The Administrative Law Judge ("ALJ") conducted a claim construction hearing (a "Markman hearing") on March 5, 2013, and issued Order No. 31: Construing the Terms of the Asserted Claims of the Patent at Issue on April 18, 2013. Respondents have also filed a motion for summary determination of non-infringement based in part on the ALJ's claim construction of the phrase "entire ring oscillator variable speed clock," as well as similar phrases that include the term "entire" in the claims of the '336 patent. If the ALJ grants Respondents' motion, he will likely issue an initial determination that Respondents do not infringe the '336 patent. Such a ruling would then be the subject of an internal appeal at the ITC. Although the Company has opposed Respondents' motion for summary determination and believes its infringement allegations are meritorious, the Company cannot provide any guidance regarding the likelihood of a favorable or an unfavorable decision with respect to the motion for summary determination. If the ALJ denies Respondents' motion for summary determination, the 853 Investigation will proceed to trial on June 3, 2013. A final determination is expected in the 853 Investigation by no later than January 6, 2014.

The information in this Current Report on Form 8-K is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information contained herein.

Share
New Message
Please login to post a reply